News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanguine Corporation (SGNC) Completes the Formation of Life Sciences Subsidiary


6/26/2008 9:30:32 AM

PASADENA, Calif.--(BUSINESS WIRE)--Sanguine Corporation (OTCBB:SGNC) is pleased to announce the forming of Sanguine Life Sciences, a fully owned subsidiary of Sanguine Corporation. The Company’s product, PHER-O2, is considered to be an oxygen carrier. The Life Sciences division will focus on the development of PHER-O2 as an oxygen-carrying synthetic substitute for human red blood cells and various other areas requiring oxygen profusion. PHER-O2 consists of perfluoro-decalin molecules, purified water, and a proprietary synthetic - patent pending fluorinated surfactant to hold the emulsion together. Additional bio-technology products and/or future biotechnical acquisitions are planned for inclusion in the Life Sciences division.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES